Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yehuda Handelsman

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
Metabolic Syndrome and Related Disorders|March 29, 2008
Guest editorialYehuda Handelsman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 31, 2003
Treatment of the insulin resistance syndromeYehuda Handelsman,
Toxicologic Pathology|December 23, 2008
Metabolic syndrome pathophysiology and clinical presentationYehuda Handelsman
The American Journal of Managed Care|December 20, 2024
Diabetes, cardiorenal, and metabolic multispecialty practice recommendations and early intensive management of cardio-renal-metabolic diseaseYehuda Handelsman
Diabetes & Vascular Disease Research|April 25, 2019
Gerald Reaven: A man for our timesYehuda Handelsman
Diabetes Care|April 29, 2011
Role of bile acid sequestrants in the treatment of type 2 diabetesYehuda Handelsman
Postgraduate Medicine|June 5, 2009
The use of the bile acid sequestrant colesevelam HCl in patients with type 2 diabetes mellitus: for glucose and lipid control. IntroductionYehuda Handelsman
Pediatric Endocrinology Reviews : PER|June 17, 2008
Treating diabetes with incretin hormones - clinical experienceYehuda Handelsman
Advances in Therapy|August 25, 2019
Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 DiabetesYehuda Handelsman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 2, 2015
POTENTIAL PLACE OF SGLT2 INHIBITORS IN TREATMENT PARADIGMS FOR TYPE 2 DIABETES MELLITUSYehuda Handelsman
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Metabolic Syndrome and Related Disorders|March 29, 2008
Guest editorialYehuda Handelsman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 31, 2003
Treatment of the insulin resistance syndromeYehuda Handelsman,
Toxicologic Pathology|December 23, 2008
Metabolic syndrome pathophysiology and clinical presentationYehuda Handelsman
The American Journal of Managed Care|December 20, 2024
Diabetes, cardiorenal, and metabolic multispecialty practice recommendations and early intensive management of cardio-renal-metabolic diseaseYehuda Handelsman
Diabetes & Vascular Disease Research|April 25, 2019
Gerald Reaven: A man for our timesYehuda Handelsman
Diabetes Care|April 29, 2011
Role of bile acid sequestrants in the treatment of type 2 diabetesYehuda Handelsman
Postgraduate Medicine|June 5, 2009
The use of the bile acid sequestrant colesevelam HCl in patients with type 2 diabetes mellitus: for glucose and lipid control. IntroductionYehuda Handelsman
Pediatric Endocrinology Reviews : PER|June 17, 2008
Treating diabetes with incretin hormones - clinical experienceYehuda Handelsman
Advances in Therapy|August 25, 2019
Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 DiabetesYehuda Handelsman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 2, 2015
POTENTIAL PLACE OF SGLT2 INHIBITORS IN TREATMENT PARADIGMS FOR TYPE 2 DIABETES MELLITUSYehuda Handelsman
Pageof 16